Illumina Q2 FY26 GAAP diluted EPS falls 9.4% to $1.35; revenue rises 9.5% to $1.16 billion
ILMN•Full-year outlook raised
- Illumina raised its FY 2026 revenue outlook to $4.60 billion-$4.64 billion.
- The company also lifted its non-GAAP diluted EPS view to $5.30-$5.40.
Quarterly results improve revenue and margins
- Illumina Q2 2026 revenue rose 9.5% to $1.16 billion from a year earlier; GAAP diluted EPS slipped to $1.35.
- GAAP operating margin widened 0.9 percentage points to 21.1%; non-GAAP operating margin narrowed 1.3 percentage points to 22.5%.
- Non-GAAP diluted EPS increased to $1.31; CEO Jacob Thaysen said demand for NovaSeq X remains high as workflow and multiomics capabilities expand.
